Showing results (881-890 of 945) with videos related to

Sort By:
Pageof 95
Mucosal Immunology|April 13, 2017
BMAL1 links the circadian clock to viral airway pathology and asthma phenotypesA Ehlers, W Xie, E Agapov, et al.
Human Molecular Genetics|December 17, 2008
ABCA4 disease progression and a proposed strategy for gene therapyArtur V Cideciyan, Malgorzata Swider, Tomas S Aleman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1981
Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseasesF Hirata, R del Carmine, C A Nelson, et al.
Scientific Reports|February 16, 2016
Coral community response to bleaching on a highly disturbed reefJ R Guest, J Low, K Tun, et al.
IEEE Transactions on Medical Imaging|April 9, 2014
200 MeV proton radiography studies with a hand phantom using a prototype proton CT scannerTia Plautz, V Bashkirov, V Feng, et al.
European Urology|March 8, 2020
Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-GuérinRoger Li, Debasish Sundi, Jingsong Zhang, et al.
Ecology|July 20, 2019
Measuring continuous compositional change using decline and decay in zeta diversityMelodie A McGeoch, Guillaume Latombe, Nigel R Andrew, et al.
Annals of Internal Medicine|August 21, 2001
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritisG G Illei, H A Austin, M Crane, et al.
Investigative Ophthalmology & Visual Science|October 27, 2006
Retinal disease expression in Bardet-Biedl syndrome-1 (BBS1) is a spectrum from maculopathy to retina-wide degenerationAmir A Azari, Tomas S Aleman, Artur V Cideciyan, et al.
European Urology Oncology|May 19, 2019
Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative ReviewYair Lotan, Peter C Black, Laura Caba, et al.
Pageof 95